Target intelligence / Profile preview

Thyroid hormone receptor beta 1 (TRβ1)

Target
TRβ1
Molecular classification
Nuclear receptor, Transcription factor, DNA-binding protein, Receptor
01

Overview

Thyroid hormone receptor beta 1 (TRβ1) is a member of the nuclear hormone receptor superfamily, encoded by the THRB gene. It functions as a ligand-dependent transcription factor activated by binding thyroid hormones, especially triiodothyronine (T3), regulating the transcription of numerous genes involved in development, metabolism, and differentiation[3][1][6][2]. TRβ1 plays major roles in the central nervous system, auditory and visual sensory systems, as well as in overall metabolic regulation[7][9][5]. Mutations in the gene or abnormal function are associated with generalized thyroid hormone resistance, certain cancers, metabolic and neurological disorders[6][3][5]. TRβ1 is a prominent therapeutic target for novel thyroid hormone mimetics aiming to treat metabolic disorders like nonalcoholic steatohepatitis (NASH) while minimizing cardiac and bone side effects[5].

Other names
Thyroid hormone receptor beta-1TR-beta 1Nuclear receptor subfamily 1 group A member 2 (NR1A2)c-erbA-2c-erbA-betaERBA2THR1Nuclear receptor thyroid hormone beta-1
02

Mechanism of action

Agonist binding leads to activation of gene transcription via thyroid hormone response elements Repressors block transcription in the absence of ligand Some synthetic agonists selectively activate TRβ1

03

Biological functions

Regulation of transcriptionMediates thyroid hormone (triiodothyronine, T3) effectsRegulation of central nervous system developmentAuditory and visual system developmentCell differentiationRegulation of metabolic processes
04

Disease associations

Congenital thyroid hormone resistanceCancerNeurological disordersMetabolic disordersSensory deficits (hearing, vision)
05

Safety considerations

Risk of thyrotoxicosis or altered metabolism with inappropriate activationCardiac toxicity with non-selective activationOff-target effects in non-target tissuesDifficulty separating beneficial metabolic effects from undesired cardiac/CNS effects
06

Interacting drugs

Triiodothyronine (T3)

4 more in the full profile.

07

Biomarkers

Elevated T3/T4 with inappropriately normal or elevated TSH (in thyroid hormone resistance)Mutations in THRB geneExpression levels of thyroid-responsive genes

Beyond the preview

Go deeper on Thyroid hormone receptor beta 1 (TRβ1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thyroid hormone receptor beta 1 (TRβ1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call